A Phase III, randomized, double-blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients
Clinical Trial Grant
Administered By
Pediatrics, Pulmonary and Sleep Medicine
Awarded By
Savara Inc.
Start Date
November 20, 2017
End Date
December 31, 2020
Administered By
Pediatrics, Pulmonary and Sleep Medicine
Awarded By
Savara Inc.
Start Date
November 20, 2017
End Date
December 31, 2020